Amgen 2007 Annual Report Download - page 113

Download and view the complete annual report

Please find page 113 of the 2007 Amgen annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 180

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176
  • 177
  • 178
  • 179
  • 180

Exhibit No. Description
4.4 First Supplemental Indenture, dated February 26, 1997. (Filed as an exhibit to Form 8-K on March
14, 1997 and incorporated herein by reference.)
4.5 8-
1
⁄
8
% Debentures due April 1, 2097. (Filed as an exhibit to Form 8-K filed on April 8, 1997 and
incorporated herein by reference.)
4.6 Officer’s Certificate, dated as of January 1, 1992, as supplemented by the First Supplemental
Indenture, dated as of February 26, 1997, establishing a series of securities entitled “8
1
⁄
8
%
Debentures due April 1, 2097.” (Filed as an exhibit to Form 8-K filed on April 8, 1997 and
incorporated herein by reference.)
4.7 Form of Liquid Yield Option™ Note due 2032. (Filed as an exhibit to Form 8-K on March 1, 2002
and incorporated herein by reference.)
4.8 Indenture, dated as of March 1, 2002. (Filed as an exhibit to Form 8-K on March 1, 2002 and
incorporated herein by reference.)
4.9 First Supplemental Indenture, dated March 2, 2005. (Filed as an exhibit to Form 8-K filed on
March 4, 2005 and incorporated herein by reference.)
4.10 Indenture, dated as of August 4, 2003. (Filed as an exhibit to Form S-3 Registration Statement on
August 4, 2003 and incorporated herein by reference.)
4.11 Form of 4.00% Senior Note due 2009. (Filed as an exhibit to Form 8-K on November 19, 2004
and incorporated herein by reference.)
4.12 Form of 4.85% Senior Notes due 2014. (Filed as an exhibit to Form 8-K on November 19, 2004
and incorporated herein by reference.)
4.13 Officers’ Certificate, dated November 18, 2004, including forms of the 4.00% Senior Notes due
2009 and 4.85% Senior Notes due 2014. (Filed as an exhibit to Form 8-K on November 19, 2004
and incorporated herein by reference.)
4.14 Registration Rights Agreement, dated as of November 18, 2004, among Amgen Inc. and Morgan
Stanley & Co. Incorporated and Merrill Lynch, Pierce, Fenner & Smith Incorporated. (Filed as an
exhibit to Form 8-K on November 19, 2004 and incorporated herein by reference.)
4.15 Form of Zero Coupon Convertible Note due 2032. (Filed as an exhibit to Form 8-K on May 6,
2005 and incorporated herein by reference.)
4.16 Indenture, dated as of May 6, 2005. (Filed as an exhibit to Form 8-K on May 6, 2005 and
incorporated herein by reference.)
4.17 Indenture, dated as of February 17, 2006 and First Supplemental Indenture, dated as of June 8,
2006 (including form of 0.125% Convertible Senior Note due 2011). (Filed as exhibit to Form
10-Q for the quarter ended June 30, 2006 on August 9, 2006 and incorporated herein by
reference).
4.18 Indenture, dated as of February 17, 2006 and First Supplemental Indenture, dated as of June 8,
2006 (including form of 0.375% Convertible Senior Note due 2013). (Filed as exhibit to Form
10-Q for the quarter ended June 30, 2006 on August 9, 2006 and incorporated herein by
reference).
4.19 Registration Rights Agreement, dated as of February 17, 2006, among Amgen Inc. and Merrill
Lynch, Pierce, Fenner & Smith Incorporated, Morgan Stanley & Co. Incorporated, Citigroup
Global Markets Inc., JPMorgan Securities Inc., Lehman Brothers Inc., Bear, Stearns & Co. Inc.,
Credit Suisse Securities (USA) LLC. (Filed as an exhibit to Form 8-K on February 21, 2006 and
incorporated herein by reference.)
101